By Mariana García Corral
TMCx demo day is the culmination of a 4 month program whose goal is to quickly and effectively connect entrepreneurs and stakeholders. During this program WeaRobot’s team gained insights from experts on every facet of their business and was able to build relationships with key thought leaders and mentors. During TMCx demo day, on November 17, 2016, they gave an exclusive presentation to hundreds of investors, corporate partners, hospital stakeholders, media and other guests.
WeaRobot made a demonstration of their first prototype of a modular exoskeleton which will use brain and muscle signals to determine the precise instant when the user requires torque in the joints. The purpose of this device is to improve mobility for seniors and to help rehabilitation patients to have a faster recovery time. Their next step is to launch their refined prototype MRLN1 and to go into safety and clinical trials by the end of this year.
“The contact with Texas Medical Center is a great opportunity to validate our business model and clinical applications and it has also helped us understand how the US market works”. Ernesto Rodríguez Leal, WeaRobot’s CEO
More information at:
Download Newsletter here.